Paste your Google Webmaster Tools verification code here

Baxalta Ventures, Mayo Clinic and Velocity Pharmaceutical Development formed Vitesse Biologics in June 2015 to focus on the development of antibody and protein-based therapeutics in the areas of immunology, hematology, and oncology.

baxalta

mayoclinic

vpd